Vaccinia virus polypeptides
    13.
    发明授权
    Vaccinia virus polypeptides 有权
    牛痘病毒多肽

    公开(公告)号:US09389232B2

    公开(公告)日:2016-07-12

    申请号:US14173550

    申请日:2014-02-05

    摘要: This document provides methods and materials related to polypeptides present in a vaccinia virus (e.g., polypeptides that can be isolated from naturally processed and presented class I polypeptides originating from vaccinia virus, a member of the Orthopoxvirus family). For example, methods for generating a vaccine comprising one or more of vaccinia virus polypeptides disclosed herein for preventing or treating Orthopoxvirus infection are provided. In addition, kits related to the use of vaccinia polypeptides are provided.

    摘要翻译: 本文件提供了与痘苗病毒中存在的多肽相关的方法和材料(例如可以从天然加工的和来源于痘苗病毒的I型多肽,正型疱疹病毒家族的成员分离的多肽)。 例如,提供了用于产生包含一种或多种本文公开的用于预防或治疗异痘病毒感染的痘苗病毒多肽的疫苗的方法。 此外,提供了与使用痘苗多肽有关的试剂盒。

    METHOD FOR DETERMINATION OR EVALUATION OF TEST SUBSTANCE
    15.
    发明申请
    METHOD FOR DETERMINATION OR EVALUATION OF TEST SUBSTANCE 有权
    测试物质的测定方法

    公开(公告)号:US20130122512A1

    公开(公告)日:2013-05-16

    申请号:US13806979

    申请日:2011-06-23

    IPC分类号: C12Q1/68 G01N33/68

    摘要: An object of the present invention is to provide a method for determination or evaluation of an extract from inflamed tissues inoculated with vaccinia virus where the enhancement of activation of neurotrophic factor such as BDNF in cultured cells or the enhancement of activation of proteins participating therein is used as an indicator. The present invention relates to a novel method for determination or evaluation of an extract from inflamed tissues inoculated with vaccinia virus and relates to a method for determination or evaluation of the extract where the enhancement of production of neurotrophic factor such as BDNF in cultured cells or the enhancement of activation of various proteins in intracellular signaling pathway participating in production of BDNF, etc. is used as an indicator.

    摘要翻译: 本发明的目的是提供一种用于确定或评估接种痘苗病毒的发炎组织的提取物的方法,其中使用培养细胞中增强神经营养因子如BDNF的活化或者使用其中参与蛋白质的活化的增强 作为指标。 本发明涉及一种用于确定或评估接种痘苗病毒的发炎组织的提取物的新方法,涉及一种用于测定或评估提取物的方法,其中增强培养细胞中BDNF等神经营养因子的产生,或 使用参与BDNF生产的细胞内信号通路中各种蛋白质的活化增强作为指标。

    Method for determination or evaluation of test substance
    19.
    发明授权
    Method for determination or evaluation of test substance 有权
    测定物质的测定方法

    公开(公告)号:US09447466B2

    公开(公告)日:2016-09-20

    申请号:US13806979

    申请日:2011-06-23

    IPC分类号: C12Q1/68 G01N33/50 G01N33/68

    摘要: An object of the present invention is to provide a method for determination or evaluation of an extract from inflamed tissues inoculated with vaccinia virus where the enhancement of activation of neurotrophic factor such as BDNF in cultured cells or the enhancement of activation of proteins participating therein is used as an indicator. The present invention relates to a novel method for determination or evaluation of an extract from inflamed tissues inoculated with vaccinia virus and relates to a method for determination or evaluation of the extract where the enhancement of production of neurotrophic factor such as BDNF in cultured cells or the enhancement of activation of various proteins in intracellular signaling pathway participating in production of BDNF, etc. is used as an indicator.

    摘要翻译: 本发明的目的是提供一种用于确定或评估接种痘苗病毒的发炎组织的提取物的方法,其中使用培养细胞中增强神经营养因子如BDNF的活化或者使用其中参与蛋白质的活化的增强 作为指标。 本发明涉及一种用于确定或评估接种痘苗病毒的发炎组织的提取物的新方法,涉及一种用于测定或评估提取物的方法,其中增强培养细胞中BDNF等神经营养因子的产生,或 使用参与BDNF生产的细胞内信号通路中各种蛋白质的活化增强作为指标。

    METHOD FOR DETERMINING THE CONCENTRATION OF VIRUS PARTICLES/VIRUS ANTIGENS
    20.
    发明申请
    METHOD FOR DETERMINING THE CONCENTRATION OF VIRUS PARTICLES/VIRUS ANTIGENS 审中-公开
    用于确定病毒颗粒/病毒抗原浓度的方法

    公开(公告)号:US20140322700A1

    公开(公告)日:2014-10-30

    申请号:US14284259

    申请日:2014-05-21

    申请人: Holger KOST

    发明人: Holger KOST

    IPC分类号: C12Q3/00 C12N7/00 G01N33/569

    摘要: The invention provides a method for determining the concentration of virus particles and/or virus antigens in a sample. In particular, the invention relates to determining the concentration of influenza virus particles/influenza virus antigens in a sample. The invention further relates to the use of an ion-exchange matrix for the determination of the concentration of virus particles and/or virus antigens in a sample.

    摘要翻译: 本发明提供了一种确定样品中病毒颗粒和/或病毒抗原浓度的方法。 特别地,本发明涉及确定样品中流感病毒颗粒/流感病毒抗原的浓度。 本发明还涉及离子交换基质用于测定样品中病毒颗粒和/或病毒抗原浓度的用途。